跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERYSON GRANULES 200 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
ERYSON GRANULES 200 mg/5 ml
Approved
THERAPEUTIC
ERYSON GRANULES 200 mg/5 ml
BEACONS PHARMACEUTICALS PTE. LTD.
🇸🇬 Health Sciences Authority
Approval Date
Jun 17, 1988
Approval ID
594103db2a5a2c1f
Company
BEACONS PHARMACEUTICALS PTE. LTD.
Type
Therapeutic
Approval Details
Approval Id
594103db2a5a2c1f
Drug Name
ERYSON GRANULES 200 mg/5 ml
Product Name
ERYSON GRANULES 200 mg/5 ml
Approval Number
SIN01860P
Approval Date
1988-06-17
Registrant
BEACONS PHARMACEUTICALS PTE. LTD.
Licence Holder
BEACONS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
GRANULE, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01FA01
Atc Item Name
erythromycin
Pharma Manufacturer Name
BEACONS PHARMACEUTICALS PTE. LTD.
Company Detail Path
/organization/beacons-pharmaceuticals-pte-ltd
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATE 234mg/5ml EQV ERYTHROMYCIN
200mg/5ml
ERYTHROMYCIN ETHYLSUCCINATE 234 MG/5 ML EQV ERYTHROMYCIN
200 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 17, 1988
Approval ID
594103db2a5a2c1f
Type
Therapeutic
Back to HSA Approvals